-
公开(公告)号：US20110218338A1
公开(公告)日：2011-09-08
申请号：US13084226
申请日：2011-04-11
申请人： Hui Cai , Frank Chavez , James P. Edwards , Anne E. Fitzgerald , Jing Liu , Neelakandha S. Mani , Danielle K. Neff , Michele C. Rizzolio , Brad M. Savall , Deborah M. Smith , Jennifer D. Venable , Jianmei Wei , Ronald L. Wolin
发明人： Hui Cai , Frank Chavez , James P. Edwards , Anne E. Fitzgerald , Jing Liu , Neelakandha S. Mani , Danielle K. Neff , Michele C. Rizzolio , Brad M. Savall , Deborah M. Smith , Jennifer D. Venable , Jianmei Wei , Ronald L. Wolin
IPC分类号： C07D403/14 , C07D403/04 , C07D413/14 , C07D405/14
CPC分类号： C07D498/04 , C07D239/48 , C07D239/70 , C07D239/95 , C07D401/04 , C07D403/04 , C07D405/04 , C07D405/14 , C07D409/14 , C07D471/04 , C07D487/04 , C07D487/08 , C07D487/10 , C07D519/00
摘要： 2-Aminopyrimidine compounds are described, which are useful as H4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritus.
摘要翻译： 描述了2-氨基嘧啶化合物，其可用作H 4受体调节剂。 这些化合物可用于治疗由H 4受体活性介导的疾病状态，病症和病症的药物组合物和方法，例如过敏，哮喘，自身免疫性疾病和瘙痒症。
-
公开(公告)号：US20110160452A1
公开(公告)日：2011-06-30
申请号：US13043420
申请日：2011-03-08
申请人： Hui Cai , Frank Chavez , James P. Edwards , Anne E. Fitzgerald , Jing Liu , Neelakandha S. Mani , Danielle K. Neff , Michele C. Rizzolio , Brad M. Savall , Deborah M. Smith , Jennifer D. Venable , Jianmai Wei , Ronald L. Wolin
发明人： Hui Cai , Frank Chavez , James P. Edwards , Anne E. Fitzgerald , Jing Liu , Neelakandha S. Mani , Danielle K. Neff , Michele C. Rizzolio , Brad M. Savall , Deborah M. Smith , Jennifer D. Venable , Jianmai Wei , Ronald L. Wolin
IPC分类号： C07D403/04 , C07D401/04 , C07D403/14 , C07D498/04
CPC分类号： C07D498/04 , C07D239/48 , C07D239/70 , C07D239/95 , C07D401/04 , C07D403/04 , C07D405/04 , C07D405/14 , C07D409/14 , C07D471/04 , C07D487/04 , C07D487/08 , C07D487/10 , C07D519/00
摘要： 2-Aminopyrimidine compounds are described, which are useful as H4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.
-
3.发明授权
公开(公告)号：US5545637A
公开(公告)日：1996-08-13
申请号：US459991
申请日：1995-06-02
IPC分类号： C07D307/83 , C07D407/00 , A61K9/00 , A61K31/535 , A61K31/5377 , A61P31/12 , A61P35/00 , A61P37/06 , C07D295/00 , C07D307/88 , C07D413/12
CPC分类号： C07D307/88
摘要： The crystalline anhydrous salt formed by complexing mycophenolate mofetil with an anion selected from the group chloride, sulfate, phosphate and acetate (in particular the hydrochloride salt), and pharmaceutical compositions, intravenous formulations and a kit thereof, and associated methods of treatment.
摘要翻译： 通过将霉酚酸酯与选自氯化物，硫酸盐，磷酸盐和乙酸盐（特别是盐酸盐）的阴离子和药物组合物，静脉内制剂及其试剂盒以及相关的治疗方法络合形成的结晶无水盐。
-
公开(公告)号：US20080194577A1
公开(公告)日：2008-08-14
申请号：US12070051
申请日：2008-02-14
申请人： Hui Cai , Frank Chavez , James P. Edwards , Anne E. Fitzgerald , Jing Liu , Neelakandha S. Mani , Danielle K. Neff , Michele C. Rizzolio , Brad M. Savall , Deborah M. Smith , Jennifer D. Venable , Jianmei Wei , Ronald L. Wolin
发明人： Hui Cai , Frank Chavez , James P. Edwards , Anne E. Fitzgerald , Jing Liu , Neelakandha S. Mani , Danielle K. Neff , Michele C. Rizzolio , Brad M. Savall , Deborah M. Smith , Jennifer D. Venable , Jianmei Wei , Ronald L. Wolin
IPC分类号： A61K31/496 , C07D239/48 , A61K31/505 , A61P37/08 , C07K14/705 , A61P17/00 , A61P29/00 , C07D403/04
CPC分类号： C07D498/04 , C07D239/48 , C07D239/70 , C07D239/95 , C07D401/04 , C07D403/04 , C07D405/04 , C07D405/14 , C07D409/14 , C07D471/04 , C07D487/04 , C07D487/08 , C07D487/10 , C07D519/00
摘要： 2-Aminopyrimidine compounds are described, which are useful as H4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.
摘要翻译： 描述了2-氨基嘧啶化合物，其可用作H 4 S 5受体调节剂。 这样的化合物可以用于治疗由H 4 S受体活性介导的疾病状态，病症和病症的药物组合物和方法，例如过敏，哮喘，自身免疫疾病和瘙痒症。
-
公开(公告)号：US20110160451A1
公开(公告)日：2011-06-30
申请号：US13043391
申请日：2011-03-08
申请人： Hui CAI , Frank CHAVEZ , James P. EDWARDS , Anne E. FITZGERALD , Jing LIU , Neelakandha S. MANI , Danielle K. NEFF , Michele C. RIZZOLIO , Brad M. SAVALL , Deborah M. SMITH , Jennifer D. VENABLE , Jianmei WEI , Ronald L. WOLIN
发明人： Hui CAI , Frank CHAVEZ , James P. EDWARDS , Anne E. FITZGERALD , Jing LIU , Neelakandha S. MANI , Danielle K. NEFF , Michele C. RIZZOLIO , Brad M. SAVALL , Deborah M. SMITH , Jennifer D. VENABLE , Jianmei WEI , Ronald L. WOLIN
IPC分类号： C07D403/04 , C07D401/04 , C07D487/04 , C07D471/04 , C07D487/08 , C07D405/14 , C07D487/10 , C07D498/04 , C07D491/052 , C07D239/48 , C07D409/14 , C07D409/06
CPC分类号： C07D498/04 , C07D239/48 , C07D239/70 , C07D239/95 , C07D401/04 , C07D403/04 , C07D405/04 , C07D405/14 , C07D409/14 , C07D471/04 , C07D487/04 , C07D487/08 , C07D487/10 , C07D519/00
摘要： 2-Aminopyrimidine compounds are described, which are useful as H4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.
摘要翻译： 描述了2-氨基嘧啶化合物，其可用作H 4受体调节剂。 这些化合物可用于治疗由H 4受体活性介导的疾病状态，病症和病症的药物组合物和方法，例如过敏，哮喘，自身免疫性疾病和瘙痒症。
-
6.发明授权
公开(公告)号：US5543408A
公开(公告)日：1996-08-06
申请号：US349236
申请日：1994-12-05
IPC分类号： C07D307/83 , C07D407/00 , A61K9/00 , A61K31/535 , A61K31/5377 , A61P31/12 , A61P35/00 , A61P37/06 , C07D295/00 , C07D307/88 , C07D413/12
CPC分类号： C07D307/88
摘要： The crystalline anhydrous salt formed by complexing mycophenolate mofetil with an anion selected from the group chloride, sulfate, phosphate and acetate (in particular the hydrochloride salt), and pharmaceutical compositions, intravenous formulations and a kit thereof, and associated methods of treatment.
摘要翻译： 通过将霉酚酸酯与选自氯化物，硫酸盐，磷酸盐和乙酸盐（特别是盐酸盐）的阴离子和药物组合物，静脉内制剂及其试剂盒以及相关的治疗方法络合形成的结晶无水盐。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.013 秒)
